The GLP-1 agonist treatments had no effect on the severity of diabetic retinopathy [14], while other studies showed that the GLP-1 agonist treatment is associated with an increased risk (odds ratio: 1.23) of rapidly worsening diabetic retinopathy [13]. Here, GCG is linked to diabetic retinopathy.